Medical News

RSS

Bipartisan deficit commission unlikely to make big Medicare changes

National Journal: "For all of the attention surrounding President Obama's bipartisan commission on deficit reduction, the country's biggest cost centers — health care in general and Medicare specifically — will likely remain unscathed when the panel offers its recommendations in December.

1 Oct 2010

Health insurance prices, restrictions now on federal consumer website

Kaiser Health News staff writer Jessica Marcy talked with Todd Park, the chief technology officer of the Department of Health and Human Services, and Karen Pollitz, who heads the consumer support division at HHS Office of Consumer Information and Insurance Oversight, about the detailed health plan cost and benefits information unveiled today on Healthcare.gov.

1 Oct 2010

Political cartoon: 'Don't Worry'

Kaiser Health News provides a fresh take on health policy developments with "Don't Worry" by Chip Bok.

1 Oct 2010

Med schools say doctor shortage to worsen under new health law

The new health law will worsen the physician shortage as newly insured patients seek care, according to a new report from the Association of American Medical Colleges.

1 Oct 2010

Merck to pay millions over Mass. allegations of inflated wholesale rate

Bloomberg Businessweek: A Massachusetts court ordered the drug maker Merck to pay $4.6 million in damages for inflating wholesale prices for generic asthma drugs. "Massachusetts claimed the companies reported inflated wholesale acquisition-cost prices for the generics, and that MassHealth, the state component of the Medicaid program, would rely on those prices for reimbursements" (McQuillen, 9/30).

1 Oct 2010

Today's OpEds: Sebelius' tough talk; Changing the malpractice system; Different perspectives on the health overhaul

The problem is, quite simply, the centerpiece of the entire health care overhaul -- guaranteed coverage for so-called "preexisting" conditions. As long as both parties insist on this, the national discussion over real health care reform is going nowhere (Jason Lewis, 9/30).

1 Oct 2010

Argos' AGS-003 in combination with sunitinib demonstrates favorable PFS for renal cell carcinoma

Argos Therapeutics announced that its Arcelis immunotherapy for renal cell carcinoma (RCC), AGS-003, demonstrated favorable progression-free survival (PFS) and safety in combination with sunitinib, based upon updated results from an ongoing Phase 2 trial.

1 Oct 2010

Encorium announces extension of expiration date for pending rights offering

Encorium Group, Inc. , a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that it has extended the expiration date for its pending rights offering from September 30, 2010 to October 15, 2010. The subscription rights may now be exercised at any time prior to 5:00 p.m. ET on Friday, October 15, 2010.

1 Oct 2010

Siblings of children with autism have language delays: Study

Siblings of children with autism have more frequent language delays and other subtle characteristics of the disorder than previously understood. Girls also may be mildly affected more often than recognized in the past.

1 Oct 2010

Activating rearrangements in receptor genes are more common than previously thought

A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,--an MSKCC surgeon, researcher and the Director of the Brain Tumor Center--and was published in the October 1 issue of the journal Genes & Development.

1 Oct 2010

Vibrant joins Bike MS NYC to raise money for National Multiple Sclerosis Society

Vibrant will participate in Bike MS NYC on Sunday, October 3 to increase awareness of Multiple Sclerosis and to raise money for the National Multiple Sclerosis Society. The race, hosted by the Southern NY Chapter of the National Multiple Sclerosis Society, will include nearly 6,000 cyclists across two Bike MS NYC locations.

1 Oct 2010

Medicago announces official groundbreaking ceremony for U.S. plant-based commercial grade vaccine facility

Medicago U.S.A. Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that company executives, along with U.S. Senator Kay Hagan (D-NC) and U.S. Congressman David Price (D-NC), are holding an official groundbreaking ceremony this morning for its U.S. plant-based commercial grade vaccine facility in Research Triangle Park, North Carolina.

1 Oct 2010

QRxPharma's A$14 million Placement oversubscribed

QRxPharma Limited has today announced a Placement which raised A$14 million and which was significantly oversubscribed.

1 Oct 2010

VirtualScopics third-quarter revenues increase 25% to $3.5 million

VirtualScopics, Inc., a provider of quantitative imaging for clinical trials, today announced revenues for the third quarter ended September 30, 2010 exceeded $3.5 million, representing a greater than 25% increase over the comparable period in 2009 and a greater than 9% growth over the preceding quarter ended June 30, 2010. Year-to-date revenues increased over 30% for the period ended September 30, 2010 compared to the same period in 2009.

1 Oct 2010

Elekta releases Atlas-based Autosegmentation 2.0 software for increasing contouring accuracy

Elekta recently launched ABAS (Atlas-based Autosegmentation) 2.0 software, which includes the Simultaneous Truth and Performance Level Estimation (STAPLE) algorithm to increase contouring accuracy. ABAS—considered the industry gold standard for autosegmentation accuracy—deforms atlases of anatomy previously defined on a reference image onto a new patient image, creating a new structure set fit to the patient anatomy and enhancing planning efficiency.

From Elekta 1 Oct 2010

Noven acquires global rights to Daytrana from Shire affiliates

Noven Pharmaceuticals, Inc. today announced that it has completed the acquisition of global rights to Daytrana® (methylphenidate transdermal system) from affiliates of Shire plc.

1 Oct 2010

The Carlyle Group announces completion of NBTY acquisition

Global alternative asset manager The Carlyle Group and NBTY, Inc., a leading global manufacturer and marketer of nutritional supplements, today announced that Carlyle has completed its $4 billion acquisition of NBTY.

1 Oct 2010

Collagen Matrix's new Collagen Dental Membrane granted FDA 510(k) clearance

Collagen Matrix, Inc., the leader in collagen- and mineral-based matrix engineering, announced today that it has received FDA's 510(k) clearance of a new Collagen Dental Membrane derived from porcine dermis indicated for use in oral surgical procedures involving guided tissue and bone regeneration.

1 Oct 2010

After McDonald's flap, White House says it will exercise 'discretion' on medical loss ratios

The Wall Street Journal: The Obama administration said Thursday that Health and Human Services Secretary Kathleen Sebelius will "exercise her discretion" in enforcing the medical loss ratio requirement of the health law. The comment comes after a report in The Journal Thursday that "McDonald's warned federal regulators it could drop its health-insurance plan for nearly 30,000 restaurant workers unless regulators waive a new requirement of the health overhaul.

1 Oct 2010

LSUHSC-S receives $3.9M NIDA grant to develop EMB-001 drug for cocaine dependence

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for addiction and obesity, announced today that the Louisiana State University Health Sciences Center (LSUHSC-S) has received a $3.9 million dollar grant from the National Institute on Drug Abuse (NIDA). The grant will support the next stages of development for Embera's drug candidate EMB-001 to treat cocaine dependence, as well as advance EMB-001 into clinical testing.

1 Oct 2010

Medical News

Bipartisan deficit commission unlikely to make big Medicare changes

Health insurance prices, restrictions now on federal consumer website

Political cartoon: 'Don't Worry'

Med schools say doctor shortage to worsen under new health law

Merck to pay millions over Mass. allegations of inflated wholesale rate

Today's OpEds: Sebelius' tough talk; Changing the malpractice system; Different perspectives on the health overhaul

Argos' AGS-003 in combination with sunitinib demonstrates favorable PFS for renal cell carcinoma

Encorium announces extension of expiration date for pending rights offering

Siblings of children with autism have language delays: Study

Activating rearrangements in receptor genes are more common than previously thought

Vibrant joins Bike MS NYC to raise money for National Multiple Sclerosis Society

Medicago announces official groundbreaking ceremony for U.S. plant-based commercial grade vaccine facility

QRxPharma's A$14 million Placement oversubscribed

VirtualScopics third-quarter revenues increase 25% to $3.5 million

Elekta releases Atlas-based Autosegmentation 2.0 software for increasing contouring accuracy

Noven acquires global rights to Daytrana from Shire affiliates

The Carlyle Group announces completion of NBTY acquisition

Collagen Matrix's new Collagen Dental Membrane granted FDA 510(k) clearance

After McDonald's flap, White House says it will exercise 'discretion' on medical loss ratios

LSUHSC-S receives $3.9M NIDA grant to develop EMB-001 drug for cocaine dependence

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News